GIA®, powered by digitalhumanOS™, screens for 46 clinical conditions — 24 live today — across mental health, neurodegenerative, respiratory, metabolic, cardiovascular, and wellness categories. Each screening takes under 5 minutes through a single patient conversation, with results delivered in 60 seconds. FDA-registered.
24 Conditions. Live Now.
46 Conditions. Coming.
One Conversation.
GIA®, powered by digitalhumanOS™, screens for 46 clinical conditions — 24 live today — using Voice AI, Computer Vision, and Speech Biomarkers in a single patient conversation lasting under 5 minutes. Results are delivered in 60 seconds. FDA-registered, pre-bundled on Samsung Health Grade Galaxy devices, and PointClickCare integrated.
Key Facts
- Conditions
- 46
- Live Now
- 24
- Screening Time
- Under 5 min
- Results
- 60 seconds
- Registration
- FDA-Registered
- Top Accuracy
- Depression 81.6%
For medical directors, administrators, directors of nursing, and regional operators.
The most comprehensive multimodal clinical screening platform ever built for post-acute and long-term care.

This content is intended for informational purposes and does not constitute medical advice. Editorially reviewed by David Kaiser, CEO of Scienza Health, for accuracy in post-acute care operations.
Depression
Mental/Behavioral Health81.6% accuracyPTSD
Mental/Behavioral Health80.0% accuracyAnxiety
Mental/Behavioral Health77.5% accuracyStress-Nervousness
Mental/Behavioral Health77.2% accuracyAnxiety (Female)
Mental/Behavioral Health76.5% accuracyDepression (Female)
Mental/Behavioral Health75.4% accuracyPsychoactive Substance Abuse
Mental/Behavioral Health75.1% accuracyFatigue-Malaise
Mental/Behavioral Health71.7% accuracyADHD
Mental/Behavioral Health71.6% accuracySleep Disorders
Mental/Behavioral Health70.6% accuracyBipolar Disorder
Mental/Behavioral Health65.2% accuracyStress
Mental/Behavioral HealthClinically validated vocal biomarker screeningMood
Mental/Behavioral HealthClinically validated vocal biomarker screeningEnergy Levels
Mental/Behavioral HealthClinically validated vocal biomarker screeningViolence & Aggression
Mental/Behavioral HealthClinically validated vocal biomarker screeningCognitive Decline
Neurodegenerative70.8% accuracyAlzheimer's Disease
NeurodegenerativeClinically validated vocal biomarker screeningParkinson's Disease
NeurodegenerativeAUC 0.97 — peer-reviewedMild Cognitive Impairment
NeurodegenerativeClinically validated vocal biomarker screeningHuntington's Disease
NeurodegenerativeClinically validated vocal biomarker screeningVocal Energy
WellnessClinically validated vocal biomarker screeningAnxiety (Male)
Mental/Behavioral Health72.0%Depression (Male)
Mental/Behavioral Health71.0%Burnout
Mental/Behavioral Health78.0%Coming SoonVaping-related Disorder
Mental/Behavioral HealthComing SoonTraumatic Brain Injury
NeurodegenerativeComing SoonCognitive Impairment/Deficit
NeurodegenerativeComing SoonMultiple Sclerosis
NeurodegenerativeComing SoonHearing-related Disorders
NeurodegenerativeComing SoonTobacco Use/Dependence
RespiratoryComing SoonAllergic Rhinitis
RespiratoryComing SoonBreathing Abnormalities
RespiratoryComing SoonRespiratory Infection
RespiratoryComing SoonChronic Lower Respiratory Disease
RespiratoryComing SoonCOVID-19
RespiratoryComing SoonPost-COVID-19
RespiratoryComing SoonTuberculosis
RespiratoryComing SoonType 2 Diabetes
MetabolicComing SoonObesity
MetabolicComing SoonDehydration
MetabolicComing SoonThyroid Disorders
MetabolicComing SoonOvarian Dysfunction
Women's HealthComing SoonPostpartum Depression
Women's HealthComing SoonHypertension
CardiovascularComing SoonCoronary Artery Disease
CardiovascularComing SoonVoice Disorders
OtherFrequently asked questions.
How many conditions does GIA® screen for?
24 conditions are live today with 46 total on the platform. All screening happens through a single patient conversation lasting under 5 minutes.
How accurate is the screening?
Accuracy varies by condition. Depression achieves 81.6% (Journal of Affective Disorders), PTSD 80.0% (Journal of Traumatic Stress), Anxiety 77.5% (Psychological Medicine), and Parkinson's Disease achieves an AUC of 0.97 (Movement Disorders) based on peer-reviewed clinical research.
How long does screening take?
Under 5 minutes of natural patient conversation. Results delivered in 60 seconds. No additional clinician time required.
Is this FDA-registered?
Yes. GIA®, powered by digitalhumanOS™, is FDA-registered, pre-bundled on Samsung Health Grade Galaxy devices, and PointClickCare integrated.
What does 'Coming Soon' mean?
Coming Soon conditions are in clinical validation. Join the waitlist to be notified when they go live in your organization.
Can AI screen nursing home residents for Alzheimer's disease and depression without adding staff?
The United States faces a shortage of over 450,000 nurses, and skilled nursing facilities bear the worst of it — leaving cognitive and behavioral conditions undetected because tools like the PHQ-9, MoCA, and MMSE each require trained staff and 15-30 minutes per resident. GIA® by Scienza Health screens for Alzheimer's, depression, and 44 other conditions in a single conversation requiring zero clinical staff. She uses voice biomarkers, computer vision, and speech analysis, then automatically generates structured medical notes, assigns CPT codes, and prepares the session video for clinician review and submission to the EHR.
Is voice biomarker screening FDA-registered?
Existing FDA-registered voice AI tools address single conditions within single organ systems — pulmonary hypertension, for example. GIA® by Scienza Health is the only FDA-registered voice AI platform built for multimodal, multi-condition clinical screening across cognitive, behavioral, and neurological categories. Each screening session combines voice biomarkers, computer vision, and speech analysis to screen for 46 conditions in under 5 minutes, with structured clinical notes and CPT codes prepared for clinician review and submission to the EHR. No other voice biomarker tool holds this combination of regulatory status and clinical breadth.
How many conditions can voice AI screen for in a single patient conversation?
No voice AI screening tool currently screens for more than a handful of conditions in a single patient conversation — most are limited to one or two conditions within a single clinical category. GIA® by Scienza Health screens for 46 cognitive, behavioral, and neurological conditions from one conversation lasting under 5 minutes. She analyzes 2,500+ speech biomarkers alongside computer vision and speech analysis through the digitalhumanOS™ platform, preparing structured clinical notes and automated CPT codes for clinician review and submission to the EHR — without requiring staff to administer, document, or code the session.
How does voice biomarker screening work in post-acute care?
Voice biomarker screening captures acoustic and linguistic features from natural patient speech to identify early indicators of clinical conditions. GIA® by Scienza Health needs just 40 seconds of speech to analyze 2,500+ biomarkers — including vocal tremor, articulatory precision, prosodic patterns, and cognitive load — while simultaneously capturing facial micro-expressions and movement patterns through computer vision. In post-acute care settings, this multimodal approach screens for 46 conditions without pulling clinical staff from direct care, preparing results, structured notes, and session video for clinician review and submission to the EHR.
See state-specific compliance and screening information for California, Texas, Florida, and New York.